CD34+ Stem Cell Augmentation of Elutriated Allogeneic Bone Marrow Grafts: Results of a Phase II Clinical Trial of Engraftment and Graft-Versus-Host Disease Prophylaxis in High-Risk Hematologic Malignancies

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1701476

Related search